Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Little is known about how some drugs affect inflammation or clotting factors in people
receiving hemodialysis. It is not yet known if these drugs help prevent heart damage as they
do in people not undergoing hemodialysis or whether they could increase the risk of heart
problems. The purpose of the study is to measure certain chemicals in the blood and see how
those chemicals may change during hemodialysis when certain drugs are given.
Phase:
Phase 2
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center